Your browser doesn't support javascript.
loading
Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study.
Imamura, Fumiaki; Schulze, Matthias B; Sharp, Stephen J; Guevara, Marcela; Romaguera, Dora; Bendinelli, Benedetta; Salamanca-Fernández, Elena; Ardanaz, Eva; Arriola, Larraitz; Aune, Dagfinn; Boeing, Heiner; Dow, Courtney; Fagherazzi, Guy; Franks, Paul W; Freisling, Heinz; Jakszyn, Paula; Kaaks, Rudolf; Khaw, Kay-Tee; Kühn, Tilman; Mancini, Francesca R; Masala, Giovanna; Chirlaque, Maria-Dolores; Nilsson, Peter M; Overvad, Kim; Pala, Valeria M; Panico, Salvatore; Perez-Cornago, Aurora; Quirós, Jose R; Ricceri, Fulvio; Rodríguez-Barranco, Miguel; Rolandsson, Olov; Sluijs, Ivonne; Stepien, Magdalena; Spijkerman, Annemieke M W; Tjønneland, Anne; Tong, Tammy Y N; Tumino, Rosario; Vissers, Linda E T; Ward, Heather A; Langenberg, Claudia; Riboli, Elio; Forouhi, Nita G; Wareham, Nick J.
Afiliación
  • Imamura F; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Schulze MB; Department of Molecular Epidemiology, Germen Institute of Human Nutrition, Potsdam, Germany.
  • Sharp SJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Guevara M; IDISNA Navarra Health Research Institute, Pamplona, Spain.
  • Romaguera D; CIBER Epidemiology and Public Health, Madrid, Spain.
  • Bendinelli B; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Salamanca-Fernández E; Health Research Institute of Balearic Islands (IdISBa), Palma de Mallorca, Spain.
  • Ardanaz E; CIBER Physiopathology of Obesity and Nutrition, Madrid, Spain.
  • Arriola L; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Aune D; CIBER Epidemiology and Public Health, Madrid, Spain.
  • Boeing H; Andalusian School of Public Health, Institute of Investigation Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), University of Granada, Granada, Spain.
  • Dow C; IDISNA Navarra Health Research Institute, Pamplona, Spain.
  • Fagherazzi G; CIBER Epidemiology and Public Health, Madrid, Spain.
  • Franks PW; Public Health Division of Gipuzkoa, Instituto BIO-Donostia, Basque Government, CIBERESP, Gipuzkoa, Spain.
  • Freisling H; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Jakszyn P; Department of Nutrition, Bjørknes University College, Oslo, Norway.
  • Kaaks R; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
  • Khaw KT; Department of Molecular Epidemiology, Germen Institute of Human Nutrition, Potsdam, Germany.
  • Kühn T; Gustave Roussy Institute, Villejuif, France.
  • Mancini FR; University Paris-South, Faculty of Medicine, University Versailles-St Quentin, University Paris-Saclay, Villejuif, France.
  • Masala G; National Institute for Health and Medical Research (INSERM), Center for Research in Epidemiology and Population Health, Villejuif, France.
  • Chirlaque MD; Gustave Roussy Institute, Villejuif, France.
  • Nilsson PM; University Paris-South, Faculty of Medicine, University Versailles-St Quentin, University Paris-Saclay, Villejuif, France.
  • Overvad K; National Institute for Health and Medical Research (INSERM), Center for Research in Epidemiology and Population Health, Villejuif, France.
  • Pala VM; Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.
  • Panico S; Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.
  • Perez-Cornago A; Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Quirós JR; Catalan Institute of Oncology, Barcelona, Spain.
  • Ricceri F; FCS Blanquerna, Universitat Ramon Llull, Barcelona, Spain.
  • Rodríguez-Barranco M; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Rolandsson O; Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Sluijs I; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Stepien M; Gustave Roussy Institute, Villejuif, France.
  • Spijkerman AMW; University Paris-South, Faculty of Medicine, University Versailles-St Quentin, University Paris-Saclay, Villejuif, France.
  • Tjønneland A; National Institute for Health and Medical Research (INSERM), Center for Research in Epidemiology and Population Health, Villejuif, France.
  • Tong TYN; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Tumino R; CIBER Epidemiology and Public Health, Madrid, Spain.
  • Vissers LET; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Ward HA; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
  • Langenberg C; Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.
  • Riboli E; Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark.
  • Forouhi NG; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Wareham NJ; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
J Nutr ; 149(11): 1985-1993, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31396627
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Té / Café / Diabetes Mellitus Tipo 2 / Bebidas Azucaradas Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Nutr Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Té / Café / Diabetes Mellitus Tipo 2 / Bebidas Azucaradas Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Nutr Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido